New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Clinical information dashboard delayed (22 May 2019)

The new Primary Care Indicators Dashboard was due to be launched on 1 May 2019. However, NHS England have encountered a number of problems relating to formatting and resolving...
Read more »

Premises update - May 2019 (22 May 2019)

Rent review process  The rent review process applies to all practices who rent their premises, regardless of who their landlord is.  Practices have been reporting delays following applications for a...
Read more »

Tips of the month May 2019 (22 May 2019)

We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »

Improving numeracy and data skills in general practice (22 May 2019)

We all use maths every day, whether we consciously think about it or not. Staff working in healthcare are no different. Last week included National Numeracy Day, the annual celebration...
Read more »

International Nurses Day 2019 (22 May 2019)

We celebrated International Nurses Day on 12 May by highlighting the contribution of nurses on social media.   Did you know that only 11.4%...
Read more »

Primary care networks update - May 2019 (22 May 2019)

The process for setting up primary care networks (PCNs) has now moved on to the approval stage, following last week’s deadline for submitting applications. CCGs have until the end of...
Read more »

Making social prescribing work in practice (22 May 2019)

Dr Jane Myat, of the Caversham Group Practice in Camden, explains how her practice has used social prescribing to improve the wellbeing of patients and staff. From July, approved Primary...
Read more »
Next Page »
« Previous Page